OptiCleanse GHI Creamy Chocolate
On sale on the US market (according to the DSLD)
XYMOGEN, food supplement from the US market
OptiCleanse GHI Creamy Chocolate (XYMOGEN), a food supplement au code-barres 722537511506, is described by its US market label. If sold in France, it would be subject to 8 points of French or European regulation, detailed below. Doses of folates, niacine, vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250 mg a day according to the label (at most 1 serving a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5 mg a day according to the label (at most 1 serving a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Sélénium: up to 100 µg a day according to the label (at most 1 serving a day), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Chrome: up to 60 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Potassium: up to 505 mg a day according to the label (at most 1 serving a day), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 722537511506
- Form
- Powder
- One serving
- 62 g
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Cane Syrup, Dried, Cocoa, Powder, Natural Flavors, Sunflower Oil, Medium Chain Triglyceride Oil, Taurine, Glycine, Cellulose Gum, Xanthan Gum, Aminogen, Stevia Leaf Extract, L-Glutamine, Guar Gum, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 230 mg |
| Total Fat | Fat | 8 Gram(s) |
| Saturated Fat | Fat | 2 Gram(s) |
| Total Carbohydrates | Carbohydrate | 18 Gram(s) |
| Dietary Fiber | Fibre | 6 Gram(s) |
| Total Sugars | Carbohydrate | 5 Gram(s) |
| Added Sugars | Carbohydrate | 5 Gram(s) |
| Protein | Blend | 26 Gram(s) |
| Vitamin A | Vitamin | 750 µg |
| Vitamin C | Vitamin | 250 mg |
| Thiamine | Vitamin | 15 mg |
| Riboflavin | Vitamin | 5 mg |
| Niacin | Vitamin | 40 mg |
| Vitamin B6 | Vitamin | 5 mg |
| Quatrefolic | Vitamin | 340 µg DFE (dietary folate equivalent) |
| Vitamin B12 | Vitamin | 50 µg |
| Biotin | Vitamin | 150 µg |
| Pantothenic Acid | Vitamin | 35 mg |
| Choline | Vitamin | 100 mg |
| DimaCal | Mineral | 220 mg |
| Iron | Mineral | 6 mg |
| Iodine | Mineral | 60 µg |
| Magnesium | Mineral | 140 mg |
| Zinc | Mineral | 10 ng |
| Selenium | Mineral | 100 µg |
| Manganese | Mineral | 2 mg |
| Chromium | Mineral | 60 µg |
| Molybdenum | Mineral | 35 µg |
| Sodium | Mineral | 580 mg |
| Potassium | Mineral | 505 mg |
| stabilized Flaxseed (Linum usitatissimum) | Plant | 5.6 Gram(s) |
| typical Alpha-Linolenic Acid | Fatty acid | 1.25 Gram(s) |
| typical Linoleic Acid | Fatty acid | 392 mg |
| Pomegranate Whole Fruit Extract (Punica granatum) | Plant | 400 mg |
| Betaine Anhydrous | Other substance | 250 mg |
| Lemon Bioflavonoid Complex | Other substance | 250 mg |
| Quercetin | Other substance | 250 mg |
| Potassium D-Glucarate | Mineral | 250 mg |
| Rutin | Other substance | 200 mg |
| Turmeric Rhizome Extract (Curcuma longa) | Plant | 200 mg |
| N-Acetyl-L-Cysteine | Other substance | 150 mg |
| Ginger | Plant | 150 mg |
| Methylsulfonylmethane | Other substance | 120 mg |
| Sodium Sulfate Anhydrous | Mineral | 100 mg |
| Green Tea Aqueous Leaf Extract (Camellia sinensis) | Plant | 82 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: OptiCleanse GHI Creamy Chocolate
Entered into DSLD on 25 September 2023. Withdrawn from the US market on 8 September 2023 (according to the DSLD).- Active ingredient added : Alpha Linolenic Acid (1.28 Gram(s))
- Active ingredient removed : typical Alpha-Linolenic Acid (1.25 Gram(s))
- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (220 mg)
- Same quantity, different name: Preventium in this version; Potassium D-Glucarate on the displayed label (250 mg)
- Same quantity, different name: Folate in this version; Quatrefolic on the displayed label (340 mcg DFE)
- Same quantity, different name: Turmeric extract in this version; Turmeric Rhizome Extract on the displayed label (200 mg)
- Same quantity, different name: Linoleic Acid in this version; typical Linoleic Acid on the displayed label (392 mg)
- Different unit, without conversion : Calories: 230 Calorie(s) in this version; 230 mg on the displayed label
- Different unit, without conversion : Zinc: 10 mg in this version; 10 ng on the displayed label
Official label: OptiCleanse GHI Creamy Chocolate
Entered into DSLD on 26 December 2020. Withdrawn from the US market on 18 August 2022 (according to the DSLD).- Active ingredient added : Alpha-Linolenic Acid (1.28 Gram(s))
- Active ingredient added : Folate (200 mcg DFE)
- Active ingredient added : Watercress (100 mg)
- Active ingredient removed : Quatrefolic (340 mcg DFE)
- Active ingredient removed : typical Alpha-Linolenic Acid (1.25 Gram(s))
- Same quantity, different name: Calcium in this version; DimaCal on the displayed label (220 mg)
- Same quantity, different name: Green Tea aqueous extract in this version; Green Tea Aqueous Leaf Extract on the displayed label (82 mg)
- Same quantity, different name: Pomegranate extract in this version; Pomegranate Whole Fruit Extract on the displayed label (400 mg)
- Same quantity, different name: BCM-95 Turmeric extract in this version; Turmeric Rhizome Extract on the displayed label (200 mg)
- Same quantity, different name: Linoleic Acid in this version; typical Linoleic Acid on the displayed label (392 mg)
- Different unit, without conversion : Calories: 230 Calorie(s) in this version; 230 mg on the displayed label
- Different unit, without conversion : Zinc: 10 mg in this version; 10 ng on the displayed label
Official label: OptiCleanse GHI Creamy Chocolate
Entered into DSLD on 23 March 2012. Withdrawn from the US market on 12 June 2013 (according to the DSLD).- Active ingredient added : Betaine (250 mg)
- Active ingredient added : Calcium (200 mg)
- Active ingredient added : Calories from Fat (60 {Calories})
- Active ingredient added : Cholesterol (0 mg)
- Active ingredient added : Curcumin (200 mg)
- Active ingredient added : Ellagic Acid (250 mg)
- Active ingredient added : Folate (200 mcg)
- Active ingredient added : Ginger root powder (150 mg)
- Active ingredient added : Lemon Bioflavonoids (250 mg)
- Active ingredient added : MeadowPure(TM) (5.6 g)
- Active ingredient added : Monounsaturated Fat (2.2 mg)
- Active ingredient added : N-Acetyl-Cysteine (150 mg)
- Active ingredient added : Other Carbohydrates (6 g)
- Active ingredient added : Phosphorus (130 mg)
- Active ingredient added : Polyunsaturated Fat (0.5 g)
- Active ingredient added : Preventium(R) (250 mg)
- Active ingredient added : Sodium Sulfate (100 mg)
- Active ingredient added : Soluble Fiber (3 g)
- Active ingredient added : Sugar (8 g)
- Active ingredient added : Trans Fat (0 g)
- Active ingredient added : Watercress Herb Powder (100 mg)
- Active ingredient removed : Added Sugars (5 Gram(s))
- Active ingredient removed : Betaine Anhydrous (250 mg)
- Active ingredient removed : DimaCal (220 mg)
- Active ingredient removed : Ginger (150 mg)
- Active ingredient removed : Iron (6 mg)
- Active ingredient removed : Lemon Bioflavonoid Complex (250 mg)
- Active ingredient removed : N-Acetyl-L-Cysteine (150 mg)
- Active ingredient removed : Pomegranate Whole Fruit Extract (400 mg)
- Active ingredient removed : Potassium D-Glucarate (250 mg)
- Active ingredient removed : Quatrefolic (340 mcg DFE)
- Active ingredient removed : Sodium Sulfate Anhydrous (100 mg)
- Active ingredient removed : stabilized Flaxseed (5.6 Gram(s))
- Active ingredient removed : Total Sugars (5 Gram(s))
- Active ingredient removed : Turmeric Rhizome Extract (200 mg)
- Active ingredient removed : typical Alpha-Linolenic Acid (1.25 Gram(s))
- Active ingredient removed : typical Linoleic Acid (392 mg)
- Same quantity, different name: Green Tea Extract in this version; Green Tea Aqueous Leaf Extract on the displayed label (82 mg)
- Different quantity per serving : Magnesium: 150 mg in this version; 140 mg on the displayed label
- Different quantity per serving : Potassium: 600 mg in this version; 505 mg on the displayed label
- Different quantity per serving : Sodium: 270 mg in this version; 580 mg on the displayed label
- Different unit, without conversion : Calories: 230 {Calories} in this version; 230 mg on the displayed label
- Different unit, without conversion : Dietary Fiber: 4 g in this version; 6 Gram(s) on the displayed label
- Different unit, without conversion : Protein: 26 g in this version; 26 Gram(s) on the displayed label
- Different unit, without conversion : Saturated Fat: 0 g in this version; 2 Gram(s) on the displayed label
- Different unit, without conversion : Total Carbohydrates: 19 g in this version; 18 Gram(s) on the displayed label
- Different unit, without conversion : Total Fat: 6 g in this version; 8 Gram(s) on the displayed label
- Different unit, without conversion : Vitamin A: 2,500 IU in this version; 750 mcg on the displayed label
- Different unit, without conversion : Zinc: 10 mg in this version; 10 ng on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- stabilized Flaxseed
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Sources cited by Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Sources cited by Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- Pomegranate Whole Fruit Extract
Read the warning, when it applies and the studies cited
- Rutin
Read the warning, when it applies and the studies cited
RUTIN
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).
Sources cited by Health Canada (1)
- PDR 2008: Hendler SS, Rorvik D. PDR for Nutritional Supplements. 2nd edition. Montvale (NJ): Thomson Healthcare; 2008.
- Turmeric Rhizome Extract
Read the warning, when it applies and the studies cited
TURMERIC - CURCUMA LONGA - Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Sources cited by Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Sources cited by Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 26 September 2025
Turmeric -CURCUMA LONGA - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : XYMOGEN
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “OptiCleanse GHI Creamy Chocolate (XYMOGEN): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/722537511506-opticleanse-ghi-creamy-chocolate-xymogen, updated 22 March 2024.